{"id":"https://openalex.org/W3036394232","doi":"https://doi.org/10.1093/ofid/ofaa237","title":"An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?","display_name":"An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?","publication_year":2020,"publication_date":"2020-06-18","ids":{"openalex":"https://openalex.org/W3036394232","doi":"https://doi.org/10.1093/ofid/ofaa237","mag":"3036394232","pmid":"https://pubmed.ncbi.nlm.nih.gov/32676511","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7353956"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofaa237","doi":"https://doi.org/10.1093/ofid/ofaa237","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa237","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/7/ofaa237/33486728/ofaa237.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/7/7/ofaa237/33486728/ofaa237.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084249121","display_name":"Thomas P. Lodise","orcid":"https://orcid.org/0000-0002-4730-0655","observed_orcids":["https://orcid.org/0000-0002-4730-0655"]},"institutions":[{"id":"https://openalex.org/I365282","display_name":"Albany College of Pharmacy and Health Sciences","ror":"https://ror.org/014hfaw95","country_code":"US","type":"education","lineage":["https://openalex.org/I365282"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas P Lodise","raw_affiliation_strings":["Albany College of Pharmacy and Health Sciences, Albany, New York, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany College of Pharmacy and Health Sciences, Albany, New York, USA","institution_ids":["https://openalex.org/I365282"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084528915","display_name":"Sergey Izmailyan","orcid":"https://orcid.org/0000-0001-9589-7399","observed_orcids":["https://orcid.org/0000-0001-9589-7399"]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergey Izmailyan","raw_affiliation_strings":["Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0001-9589-7399","affiliations":[{"raw_affiliation_string":"Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210151614"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084066242","display_name":"Melanie Olesky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melanie Olesky","raw_affiliation_strings":["Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210151614"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063713898","display_name":"Kenneth R Lawrence","orcid":"https://orcid.org/0000-0003-2694-5216","observed_orcids":["https://orcid.org/0000-0003-2694-5216"]},"institutions":[{"id":"https://openalex.org/I4210151614","display_name":"Tetraphase Pharmaceuticals (United States)","ror":"https://ror.org/048830f73","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151614"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Lawrence","raw_affiliation_strings":["Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA"],"raw_orcid":"https://orcid.org/0000-0003-2694-5216","affiliations":[{"raw_affiliation_string":"Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA","institution_ids":["https://openalex.org/I4210151614"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5084249121"],"corresponding_institution_ids":["https://openalex.org/I365282"],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.1466,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.61619892,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"7","issue":"7","first_page":"ofaa237","last_page":"ofaa237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11080","display_name":"Surgical site infection prevention","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empirical-antibiotic-therapy","display_name":"empirical antibiotic therapy","score":0.7609999775886536},{"id":"https://openalex.org/keywords/guideline-adherence","display_name":"guideline adherence","score":0.8550000190734863},{"id":"https://openalex.org/keywords/antipseudomonal-beta-lactams","display_name":"antipseudomonal beta-lactams","score":0.8840000033378601},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.9739999771118164},{"id":"https://openalex.org/keywords/piperacillin-tazobactam","display_name":"piperacillin-tazobactam","score":0.968999981880188},{"id":"https://openalex.org/keywords/antimicrobial-stewardship","display_name":"antimicrobial stewardship","score":0.8100000023841858},{"id":"https://openalex.org/keywords/hospitalized-adults","display_name":"hospitalized adults","score":0.4350000023841858},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9652408361434937},{"id":"https://openalex.org/C2778266534","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Tazobactam","level":5,"score":0.5926297307014465},{"id":"https://openalex.org/C2776520383","wikidata":"https://www.wikidata.org/wiki/Q421713","display_name":"Ceftriaxone","level":3,"score":0.5257699489593506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49587735533714294},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.48633939027786255},{"id":"https://openalex.org/C2778478555","wikidata":"https://www.wikidata.org/wiki/Q423393","display_name":"Sulbactam","level":5,"score":0.4755506217479706},{"id":"https://openalex.org/C2777858937","wikidata":"https://www.wikidata.org/wiki/Q423376","display_name":"Piperacillin/tazobactam","level":5,"score":0.45850688219070435},{"id":"https://openalex.org/C2778193466","wikidata":"https://www.wikidata.org/wiki/Q423787","display_name":"Piperacillin","level":4,"score":0.4372970759868622},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.43612220883369446},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3646286427974701},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34372478723526},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.32823896408081055},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.1086094081401825},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofaa237","doi":"https://doi.org/10.1093/ofid/ofaa237","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa237","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/7/ofaa237/33486728/ofaa237.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7353956","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7353956","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"},{"id":"pmid:32676511","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32676511","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open forum infectious diseases","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofaa237","doi":"https://doi.org/10.1093/ofid/ofaa237","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa237","pdf_url":"https://academic.oup.com/ofid/article-pdf/7/7/ofaa237/33486728/ofaa237.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3036394232.pdf","grobid_xml":"https://content.openalex.org/works/W3036394232.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2000445173","https://openalex.org/W2017565738","https://openalex.org/W2033621529","https://openalex.org/W2060051032","https://openalex.org/W2096025800","https://openalex.org/W2108565421","https://openalex.org/W2120948071","https://openalex.org/W2136076331","https://openalex.org/W2149186506","https://openalex.org/W2159957230","https://openalex.org/W2166511722","https://openalex.org/W2337544276","https://openalex.org/W2550643720","https://openalex.org/W2583549666","https://openalex.org/W2608307645","https://openalex.org/W2751867965","https://openalex.org/W2791326569","https://openalex.org/W2895369668","https://openalex.org/W2899513950","https://openalex.org/W2902250652","https://openalex.org/W2902532896","https://openalex.org/W2904230285","https://openalex.org/W2949538555","https://openalex.org/W2970521402","https://openalex.org/W2989670069"],"related_works":["https://openalex.org/W2981614487","https://openalex.org/W2266302018","https://openalex.org/W4389030139","https://openalex.org/W7156727766","https://openalex.org/W2909537939","https://openalex.org/W2443317029","https://openalex.org/W2006042275","https://openalex.org/W2766683866","https://openalex.org/W2167351407","https://openalex.org/W7095436401"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Expert":[2],"guidelines":[3],"discourage":[4],"use":[5,253],"of":[6,107,154,191,205,223,254],"antipseudomonal":[7,224],"\u03b2-lactams":[8,225],"and":[9,37,72,113,146,182,196,210,226],"fluoroquinolones":[10,227],"in":[11,247],"lower-risk":[12,43,128,134,167,231],"patients":[13,44,123,206],"with":[14,22,45,124,163],"community-acquired":[15],"complicated":[16],"intra-abdominal":[17],"infection":[18],"(CA":[19],"cIAI).":[20],"Compliance":[21],"these":[23],"recommendations":[24],"across":[25,216],"US":[26],"hospitals":[27,248],"is":[28],"unclear.":[29],"This":[30],"study":[31,50,131],"sought":[32],"to":[33,250],"determine":[34],"treatment":[35,111],"patterns":[36,112],"associated":[38,114],"outcomes":[39,115],"among":[40,230],"adult":[41],"hospitalized":[42],"CA":[46,129,135,168,232],"cIAI.":[47],"Methods":[48],"A":[49],"using":[51],"data":[52],"from":[53,91],"the":[54,76,127,138,187,240,252],"Premier":[55],"Healthcare":[56],"Database":[57],"(10/2015\u201312/2017)":[58],"was":[59,142,160,193,228],"performed.":[60],"Inclusion":[61],"criteria:":[62],"age":[63,141],"\u226518":[64],"years;":[65],"hospitalized;":[66],"had":[67,96,148],"a":[68,97,149,176],"cIAI":[69],"at":[70],"admission;":[71],"received":[73,102,172,175,180,184],"antibiotics":[74],"within":[75,104],"first":[77],"4":[78,194],"hospital":[79,99,189],"days.":[80],"Patients":[81],"were":[82,86,89,116,199,207,214],"excluded":[83],"if":[84],"they":[85],"high":[87],"risk,":[88],"transferred":[90],"another":[92],"health":[93],"care":[94],"facility,":[95],"recent":[98],"admission,":[100],"or":[101],"dialysis":[103],"30":[105],"days":[106,195],"admission.":[108],"Empiric":[109],"antibiotic":[110],"quantified.":[117],"Results":[118],"Overall,":[119,186],"46":[120],"722":[121],"(66%)":[122],"cIAIs":[125],"met":[126],"IAI":[130,136,169,233],"criteria.":[132],"Among":[133,166],"patients,":[137,170],"mean":[139],"(SD)":[140],"53.4":[143],"(18.2)":[144],"years,":[145],"71%":[147],"Charlson":[150],"Comorbidity":[151],"Index":[152],"score":[153],"0.":[155],"The":[156],"most":[157],"common":[158],"diagnosis":[159],"acute":[161],"appendicitis":[162],"peritonitis":[164],"(59.7%).":[165],"54%":[171],"piperacillin/tazobactam,":[173],"20%":[174],"fluoroquinolone":[177],"(FQ),":[178],"11%":[179],"ceftriaxone,":[181],"7%":[183],"ampicillin/sulbactam.":[185],"median":[188,197],"length":[190],"stay":[192],"costs":[198],"$12":[200],"345":[201],"USD.":[202],"Nearly":[203],"90%":[204],"discharged":[208],"home,":[209],"<1%":[211],"died.":[212],"Outcomes":[213],"similar":[215],"all":[217],"empiric":[218],"treatments":[219],"received.":[220],"Conclusions":[221],"Overuse":[222],"commonplace":[229],"patients.":[234],"These":[235],"findings":[236],"can":[237],"serve":[238],"as":[239],"basis":[241],"for":[242],"an":[243],"antimicrobial":[244],"stewardship":[245],"initiative":[246],"aspiring":[249],"reduce":[251],"broad-spectrum":[255],"antibiotics.":[256]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2020-06-25T00:00:00"}